Janesick Amanda Shaine, Dimastrogiovanni Giorgio, Vanek Lenka, Boulos Christy, Chamorro-García Raquel, Tang Weiyi, Blumberg Bruce
Department of Developmental and Cell Biology, University of California, Irvine, Irvine, California, USA.
Environ Health Perspect. 2016 Aug;124(8):1214-26. doi: 10.1289/ehp.1510352. Epub 2016 Jan 13.
In ToxCast™ Phase I, the U.S. EPA commissioned screening of 320 pesticides, herbicides, fungicides, and other chemicals in a series of high-throughput assays. The agency also developed a toxicological prioritization tool, ToxPi, to facilitate using ToxCast™ assays to predict biological function.
We asked whether top-scoring PPARγ activators identified in ToxCast™ Phase I were genuine PPARγ activators and inducers of adipogenesis. Next, we identified ToxCast™ assays that should predict adipogenesis, developed an adipogenesis ToxPi, and asked how well the ToxPi predicted adipogenic activity.
We used transient transfection to test the ability of ToxCast™ chemicals to modulate PPARγ and RXRα, and differentiation assays employing 3T3-L1 preadipocytes and mouse bone marrow-derived mesenchymal stem cells (mBMSCs) to evaluate the adipogenic capacity of ToxCast™ chemicals.
Only 5/21 of the top scoring ToxCast™ PPARγ activators were activators in our assays, 3 were PPARγ antagonists, the remainder were inactive. The bona fide PPARγ activators we identified induced adipogenesis in 3T3-L1 cells and mBMSCs. Only 7 of the 17 chemicals predicted to be active by the ToxPi promoted adipogenesis, 1 inhibited adipogenesis, and 2 of the 7 predicted negatives were also adipogenic. Of these 9 adipogenic chemicals, 3 activated PPARγ, and 1 activated RXRα.
ToxCast™ PPARγ and RXRα assays do not correlate well with laboratory measurements of PPARγ and RXRα activity. The adipogenesis ToxPi performed poorly, perhaps due to the performance of ToxCast™ assays. We observed a modest predictive value of ToxCast™ for PPARγ and RXRα activation and adipogenesis and it is likely that many obesogenic chemicals remain to be identified.
Janesick AS, Dimastrogiovanni G, Vanek L, Boulos C, Chamorro-García R, Tang W, Blumberg B. 2016. On the utility of ToxCast™ and ToxPi as methods for identifying new obesogens. Environ Health Perspect 124:1214-1226; http://dx.doi.org/10.1289/ehp.1510352.
在ToxCast™第一阶段,美国环境保护局委托在一系列高通量试验中对320种杀虫剂、除草剂、杀菌剂及其他化学品进行筛选。该机构还开发了一种毒理学优先排序工具ToxPi,以促进利用ToxCast™试验来预测生物学功能。
我们探讨了在ToxCast™第一阶段中得分最高的过氧化物酶体增殖物激活受体γ(PPARγ)激活剂是否为真正的PPARγ激活剂和成脂诱导剂。接下来,我们确定了应该能够预测成脂作用的ToxCast™试验,开发了一种成脂作用ToxPi,并研究了ToxPi对成脂活性的预测能力如何。
我们采用瞬时转染来测试ToxCast™化学品调节PPARγ和视黄酸X受体α(RXRα)的能力,并利用3T3-L1前脂肪细胞和小鼠骨髓间充质干细胞(mBMSC)进行分化试验,以评估ToxCast™化学品的成脂能力。
在得分最高的21种ToxCast™PPARγ激活剂中,只有5种在我们的试验中是激活剂,3种是PPARγ拮抗剂,其余的无活性。我们鉴定出的真正的PPARγ激活剂可诱导3T3-L1细胞和mBMSC成脂。ToxPi预测有活性的17种化学品中,只有7种促进了成脂作用,1种抑制了成脂作用,7种预测为阴性的化学品中有2种也具有成脂作用。在这9种成脂化学品中,3种激活了PPARγ,1种激活了RXRα。
ToxCast™的PPARγ和RXRα试验与PPARγ和RXRα活性的实验室测量结果相关性不佳。成脂作用ToxPi的表现较差,可能是由于ToxCast™试验的性能所致。我们观察到ToxCast™对PPARγ和RXRα激活及成脂作用有一定的预测价值,很可能还有许多致肥胖化学品有待发现。
Janesick AS, Dimastrogiovanni G, Vanek L, Boulos C, Chamorro-García R, Tang W, Blumberg B. 2016. On the utility of ToxCast™ and ToxPi as methods for identifying new obesogens. Environ Health Perspect 124:1214-1226; http://dx.doi.org/10.1289/ehp.1510352.